Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: decongesting the matter

Eur Heart J. 2015 Jun 21;36(24):1497-8.
No abstract available

MeSH terms

  • Cardiovascular Diseases / chemically induced*
  • Diabetes Mellitus / drug therapy*
  • Dipeptidyl-Peptidase IV Inhibitors / adverse effects*
  • Humans
  • Hypoglycemic Agents / adverse effects*

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents